Organicell Regenerative Medicine is an exosome therapeutics company with a focus on developing new biologic medicine.
Organicell Regenerative Medicine has raised $4.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in July 2022.
Organicell Regenerative Medicine is headquartered in Miami, United States.
Organicell Regenerative Medicine is an exosome therapeutics company with a focus on developing new biologic medicine.
Organicell Regenerative Medicine is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Organicell Regenerative Medicine — Funding & Investors." VCBacked, July 20, 2022, https://www.vcbacked.co/company/organicell-regenerative-medicine. Accessed August 14, 2026.
VCBacked. (2022). Organicell Regenerative Medicine — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/organicell-regenerative-medicine
{{cite web |title=Organicell Regenerative Medicine — Funding & Investors |url=https://www.vcbacked.co/company/organicell-regenerative-medicine |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated